TY-1091

TY-1091 · TYK Medicines, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TY-1091, covering 2024-01-30 to 2024-01-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TY-1091 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]